ZURICH -(Dow Jones)- Newly-listed Swiss biotech company Mondobiotech Holding AG (RARE.EB) Thursday said it secured a long-term contract with biochemicals company Bachem Holding AG (BANB.EB) for the development and manufacturing of small molecules called peptides. Under the agreement, Bachem will...